Victory in EPO opposition safeguards patent for breakthrough hyperkalaemia drug
In 2018, we preserved the European patent in a successful defence in EPO opposition proceedings filed by two generic pharmaceutical manufacturers.
CASE STUDIES
Global pharmaceutical company successfully defends patent for use of antidepressant medicine
We were instructed by two global pharmaceutical companies, H. Lundbeck A/S and Takeda Pharmaceuticals, to defend an opposition filed against their patent to an antidepressant medication vortioxetine (marketed as Brintellix).
Global settlement paves way for Alnylam to establish breakthrough drug
In one of the most significant patent cases of 2018/19, we fielded a 15-strong multidisciplinary team of specialist IP solicitors and patent attorneys to secure a global settlement for Alnylam Pharmaceuticals Inc.
Strategic IP approach paves way for growth of leading antibody-based pharma SME
We have been working with Alligator Bioscience AB, a Swedish SME specialising in the development of antibody-based therapeutics for cancer treatment since the company’s formation in 2001.
Robust patent prosecution for innovative life sciences SMEs
BG Research Ltd and sister company BioGene Ltd are innovative SMES in diagnostics technology, encompassing both biotechnology and biology along with electrical and mechanical aspects.
European SPC filing strategy protects valuable IP exclusivity for pharma giant
As the foundation of AstraZeneca’s respiratory biologics portfolio, targeting the underlying causes of respiratory illnesses, Fasenra® (benralizumab) is a crucial product for this multinational client.
European expertise secures patent and design success for multinational medical corporation
A long-standing relationship between Potter Clarkson and a global medical device company headquartered in Japan has resulted in hundreds of patent matters being successfully handled.
Family of patent applications provides commercial opportunities for medtech SME
The patents and design registrations successfully obtained by the team at Potter Clarkson put the necessary IP protection in place to enable Sanandco to commercialise its product in its most commercially important territories.
Patent portfolio critical to commercial success for leading biopharma group
Our biotech team brought to bear their deep scientific understanding and legal experience in patent drafting and global filing and prosecution strategy to secure commercially-focussed patent protection.